| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 45.17B | 44.26B | 50.07B | 48.71B | 57.34B | 42.08B |
| Gross Profit | 1.90B | 2.67B | 1.72B | 2.76B | 1.89B | 1.74B |
| EBITDA | 2.64B | 2.91B | 2.74B | 3.06B | 2.79B | 1.92B |
| Net Income | 1.15B | 1.44B | 772.00M | 1.23B | 1.04B | 593.00M |
Balance Sheet | ||||||
| Total Assets | 31.64B | 30.17B | 26.56B | 27.36B | 27.89B | 28.61B |
| Cash, Cash Equivalents and Short-Term Investments | 171.00M | 4.73B | 348.00M | 450.00M | 401.00M | 449.00M |
| Total Debt | 11.58B | 11.30B | 7.93B | 8.03B | 8.82B | 9.64B |
| Total Liabilities | 18.82B | 17.09B | 13.47B | 13.62B | 14.57B | 15.80B |
| Stockholders Equity | 9.60B | 9.84B | 9.81B | 10.42B | 10.06B | 9.97B |
Cash Flow | ||||||
| Free Cash Flow | 2.13B | 2.29B | 1.87B | 2.17B | 1.95B | 1.66B |
| Operating Cash Flow | 2.71B | 2.94B | 2.49B | 2.73B | 2.41B | 2.00B |
| Investing Cash Flow | -2.81B | -3.69B | -1.50B | -702.00M | -526.00M | 386.00M |
| Financing Cash Flow | -171.00M | 724.00M | -1.08B | -1.98B | -1.93B | -1.98B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | $18.12B | 12.00 | 34.98% | 9.13% | 11.43% | -8.64% | |
80 Outperform | $15.18B | 26.36 | 9.82% | 2.70% | 22.22% | 23.30% | |
76 Outperform | $8.26B | 14.33 | 64.33% | 8.45% | 7.06% | 13.61% | |
70 Outperform | $16.46B | 25.93 | 11.77% | 8.54% | -9.94% | 43.70% | |
66 Neutral | $19.14B | 60.09 | 14.67% | 8.03% | -9.94% | 34.19% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
64 Neutral | $17.13B | 21.96 | -1.05% | 6.08% | 78.85% | -108.36% |